BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8151199)

  • 1. An investigation of mast cells in two basic leprosy groups.
    Aroni K; Kontochristopoulos G; Liossi A; Panteleos D
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):634-5. PubMed ID: 8151199
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of the lepromin test--further information on the subject.
    Dharmendra
    Indian J Lepr; 1989 Jul; 61(3):387-90. PubMed ID: 2768886
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of anti-Mycobacterium leprae antibodies in leprosy patients' sera by an A60 antigen immunoassay.
    Casal M; Solis F; Linares MJ; Puig C
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):325-7. PubMed ID: 8862270
    [No Abstract]   [Full Text] [Related]  

  • 4. A quantitative and morphometric study of tryptase-positive mast cells in cutaneous leprosy lesions.
    Magalhães Gde O; Valentim Vda C; Pereira MJ; Nery JA; Illarramendi X; Antunes SL
    Acta Trop; 2008 Jan; 105(1):62-6. PubMed ID: 18082641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK; Cherian A
    Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological reactions to mycobacterial proteins in the spectrum of leprosy.
    Rada EM; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):497-500. PubMed ID: 9465162
    [No Abstract]   [Full Text] [Related]  

  • 7. Mast cells in leprosy and leprosy reaction.
    Mahaisavariya P; Jiamton S; Manonukul J; Khemngern S
    Int J Dermatol; 2000 Apr; 39(4):274-7. PubMed ID: 10809976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoimmunotherapy: its relevance in contemporary context.
    Sehgal VN; Jain S
    Int J Dermatol; 1994 Oct; 33(10):753-4. PubMed ID: 8002151
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
    Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of S-100 antigen and anti ceramide antibody in sera of leprosy patients with and without reaction.
    Narayan R; Maheshwari PK; Desikan KV; Harinath BC
    Indian J Lepr; 1997; 69(4):347-52. PubMed ID: 9474510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inside the skin: the local immune and inflammatory milieu in leprosy.
    Scollard DM
    Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

  • 15. The spectrum of tuberculosis and leprosy: what can be the significance of specific humoral responses?
    David HL
    Res Microbiol; 1990 Feb; 141(2):197-206; discussion 263-5. PubMed ID: 2111921
    [No Abstract]   [Full Text] [Related]  

  • 16. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity.
    Sieling PA; Jullien D; Dahlem M; Tedder TF; Rea TH; Modlin RL; Porcelli SA
    J Immunol; 1999 Feb; 162(3):1851-8. PubMed ID: 9973451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prolonged, perplexing pyrexia.
    Ruiz-Rivas JL; Val D; García F; Estirado E; Alonso MJ; Laguna F
    Am J Med; 2009 Nov; 122(11):1001-3. PubMed ID: 19854324
    [No Abstract]   [Full Text] [Related]  

  • 19. Leprosy reactions. New knowledge.
    Naafs B
    Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of the soluble E-receptor of human T lymphocytes by rocket electrophoresis in the serum of patients with lepromatous and tuberculoid leprosy.
    Longo IM; Moura NC; Opromolla D; Mendes NF
    Medicina (B Aires); 1991; 51(2):133-6. PubMed ID: 1820499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.